HAYLIE DAY: Open Payments
NPI 1366119752 · GREENBRIER, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,505 in 89 payments from 17 companies in 2025. Trend: 2023 $69 · 2024 $1,947 · 2025 $1,505
Food & beverage: $1,505
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $317 |
| AstraZeneca Pharmaceuticals LP | 16 | $283 |
| Novo Nordisk Inc | 13 | $202 |
| Amgen Inc. | 10 | $146 |
| Otsuka America Pharmaceutical, Inc. | 5 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
| Lilly USA, LLC | 3 | $65 |
| PFIZER INC. | 3 | $61 |
| SHIELD THERAPEUTICS INC | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
Products named: VRAYLAR, Ozempic, AIRSUPRA, REXULTI, QULIPTA, OTEZLA, FARXIGA, Kerendia.
Industry payments across AR — which companies pay providers there.
